This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Miami Beach, Feb. 6, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (DSKX), formally known as Divine Skin Inc., (the "Company"), a leading developer of personal care products, announced today that through its joint venture partner in Brazil, the Company has received the required licenses and regulatory permits to sell ten of its top products in the second largest cosmetics market in the world.
The Company has signed a logistics agreement for distribution of its products with Solcinter Sul, which is recognized in Brazil as a major player in logistics with $100 million in annual revenues. DS Healthcare is launching in the Brazilian market with ten SKU's including: Revita Shampoo, Revita COR, Spectral DNC-N, Spectral RS, Nia Shampoo, Nia Conditioner, Radia Shampoo, Radia Conditioner, Dandrene Shampoo and Oligo DX. The Company has shipped its first order in the fourth quater of 2012.
About DS Healthcare Group
DS Healthcare Group, Inc. leads in the development of biotechnology for topical, and nutritional therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers and salons. Its brands include DS Laboratories (
www.DSLaboratories.com ), Sigma Skin (
www.SigmaSkin.com ), Polaris Research Laboratories (
www.PolarisReserachLabs.com ) and Pure Guild (
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at